| 000 | 016240000a22003490004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223025153.0 | ||
| 008 | 080324s2005 ua a f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.03.Ph.D.2005.Ib.C | ||
| 100 | 0 | _aIbrahim Khalil Ibrahim | |
| 245 | 1 | 0 |
_aComparative of NMP - 22 , telomerase and BTA in the detection of bladder cancer / _cIbrahim Khalil Ibrahim ; Supervised Neveen Mostafa Elhefnawi , Emad Eldin Hamza Elgemae , Amr Medhat Massoud |
| 246 | 1 | 5 | _aدراسة قيمة بعض دلالات الاورام فى استكشاف سرطان المثانة |
| 260 |
_aCairo : _bIbrahim Khalil Ibrahim , _c2005 |
||
| 300 |
_a217Leaves : _bill. ; _c30cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Cancer institute - Department Of Clinical Pathology | ||
| 520 | _aThe diagnostic effcacy of NMP - 22 (matritech cambridge massachusetts) BTA TRAK (polymedco redmond washington) and telomerase activity (roche molecular biochemicals) was evaluated in a trial to assess their value in the detection of bladder cancer andto compare it to that of routine urine cytology | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBladder cancer | |
| 653 | 4 | _aNMP - 22 , BTA | |
| 653 | 4 | _aTumor markers | |
| 700 | 0 |
_aAmr Medhat Massoud , _eSupervisor |
|
| 700 | 0 |
_aEmad Eldin Hamza Elgemae , _eSupervisor |
|
| 700 | 0 |
_aNeveen Mostafa Elhefnawi , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c7187 _d7187 |
||